000			01442 a2200373 4500
005			20250514075124.0
264		0	_c20031202
008			200312s 0 0 eng d
022			_a0065-2598
024	7		_a10.1007/0-306-48382-3_98 _2doi
040			_aNLM _beng _cNLM
100	1		_aPowell, Richard J
245	0	0	_aBehçet's syndrome: from aetiology to treatment. _h[electronic resource]
260			_bAdvances in experimental medicine and biology _c2003
300			_a481-6 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAntibiotic Prophylaxis
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aBehcet Syndrome _xdrug therapy
650	0	4	_aColchicine _xtherapeutic use
650	0	4	_aEtanercept
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInfliximab
650	0	4	_aPenicillins _xtherapeutic use
650	0	4	_aReceptors, Tumor Necrosis Factor _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
773	0		_tAdvances in experimental medicine and biology _gvol. 528 _gp. 481-6
856	4	0	_uhttps://doi.org/10.1007/0-306-48382-3_98 _zAvailable from publisher's website
999			_c12691930 _d12691930